Sanuwave Health Inc(SNWV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:14 PM ET (Korea 11/4 06:14)
Full metrics table
| Index | - | P/E | 24.66 | EPS (ttm) | 0.24 | Insider Own | 5.42% | Shs Outstand | 8.6M | Perf Week | 15.59% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | -7.09% | Shs Float | 8.1M | Perf Month | 26.17% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | - | Inst Own | 47.87% | Short Float | 2.9% | Perf Quarter | -0.67% |
| Income | 0.01B | P/S | 1.16 | EPS this Y | - | Inst Trans | -15.19% | Short Ratio | 3.86 | Perf Half Y | -62.08% |
| Sales | 0.04B | P/B | 18.3 | EPS next 5Y | - | ROA | 41.1% | Short Interest | 0.24M | Perf YTD | -80.13% |
| Book/sh | 0.32 | P/C | 5.44 | EPS past 3/5Y | - | ROE | - | 52W High | -83.62% ($36.20) | Perf Year | -78.37% |
| Cash/sh | 1.09 | P/FCF | 12.12 | Sales past 3/5Y | 38.05% 61.12% | ROIC | 80.01% | 52W Low | 51.28% ($3.92) | Perf 3Y | 5.42% |
| Dividend Est. | - | EV/EBITDA | 30.41 | EPS Y/Y TTM | 119.59% | Gross Margin | 73.96% | Volatility(W/M) | 7.82% 7.01% | Perf 5Y | -86.82% |
| Dividend TTM | - | EV/Sales | 1.42 | Sales Y/Y TTM | 12.02% | Oper. Margin | 1.54% | ATR (14) | 0.37 | Perf 10Y | -91.21% |
| Dividend Ex-Date | - | Quick Ratio | 0.89 | EPS Q/Q | -1216.9% | Profit Margin | 32.6% | RSI (14) | 63.97 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.28 | Sales Q/Q | -4.18% | SMA20 | 10.47% ($5.37) | Beta | 1.46 | Target Price | $40 |
| Payout | - | Debt/Eq | 7.42 | Earnings | 2026/8/6 | SMA50 | 21.78% ($4.87) | Rel Volume | 0.59 | Prev Close | $5.85 |
| Employees | 55 | LT Debt/Eq | 5.41 | EPS/Sales Surpr. | - | SMA200 | -55.34% ($13.28) | Avg Volume(3M) | 0.06M | Price | $5.93 |
| IPO | 2009/9/30 | Option/Short | No/Yes | Trades | 416 | Volume | 36,208 | Change | 1.37% |
🩹 SanuWave Health (SNWV) is a U.S. medical device company focused on wound care and regenerative medicine. It develops and supplies treatment solutions targeting chronic wounds and tissue regeneration, and is a small healthcare company with hospitals and specialized wound care facilities as its primary customers.
Over the past 1 year, on the lower side
84% below its 1-year high.
Traded less than usual. That is 59% of its average volume.
SNWV makes money but has a weak balance sheet
Of every $100 in sales, $1.54 is kept as operating profit.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,466. Peers typically go for $2,828.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -86.8%. The S&P 500 did +62% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 47.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #95 of 140 in the industry
Based on market cap of $51M.
SRTS#93 Sensus Healthcare Inc $54M PER - 
COCH#94 Envoy Medical Inc $51M PER - SNWV#95 Sanuwave Health Inc $51M PER 24.7 
MYO#96 Myomo Inc $51M PER - 
MDAI#97 Spectral AI Inc $48M PER - 
FAQ
What kind of company is SNWV?
SNWV belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SNWV?
The market cap of SNWV is approximately $51M, ranking 4,833 within its sector.
What is the P/E ratio of SNWV?
SNWV has a P/E ratio of approximately 24.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SNWV?
SNWV has recorded a 52-week high of $36.20 and a low of $3.92.
